Colgate-Palmolive Company
Colgate-Palmolive Company (CL) Stock Competitors & Peer Comparison
See (CL) competitors and their performances in Stock Market.
Peer Comparison Table: Household & Personal Products Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CL | $86.33 | +1.61% | 69.8B | 24.25 | $3.56 | +2.41% |
| PG | $155.43 | +0.22% | 364.1B | 23.88 | $6.51 | +2.67% |
| UL | $62.42 | +2.19% | 153B | 23.92 | $2.61 | +3.18% |
| KMB | $134.81 | +0.88% | 44.7B | 18.44 | $7.31 | +3.73% |
| KVUE | $21.72 | -0.84% | 41.7B | 28.95 | $0.75 | +3.76% |
| EL | $95.25 | +3.87% | 34.3B | -39.36 | -$2.42 | +1.87% |
| CHD | $93.69 | +1.56% | 22.8B | 44.19 | $2.12 | +1.26% |
| SGI | $80.97 | +3.57% | 17B | 55.46 | $1.46 | +0.38% |
| CLX | $122.89 | +0.06% | 15B | 18.85 | $6.52 | +3.99% |
| HIMS | $48.32 | +0.75% | 10.5B | 61.16 | $0.79 | N/A |
Stock Comparison
CL vs PG Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, PG has a market cap of 364.1B. Regarding current trading prices, CL is priced at $86.33, while PG trades at $155.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas PG's P/E ratio is 23.88. In terms of profitability, CL's ROE is +6.80%, compared to PG's ROE of +0.31%. Regarding short-term risk, CL is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check PG's competition here
CL vs UL Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, UL has a market cap of 153B. Regarding current trading prices, CL is priced at $86.33, while UL trades at $62.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas UL's P/E ratio is 23.92. In terms of profitability, CL's ROE is +6.80%, compared to UL's ROE of +0.29%. Regarding short-term risk, CL is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check UL's competition here
CL vs KMB Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, KMB has a market cap of 44.7B. Regarding current trading prices, CL is priced at $86.33, while KMB trades at $134.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas KMB's P/E ratio is 18.44. In terms of profitability, CL's ROE is +6.80%, compared to KMB's ROE of +2.16%. Regarding short-term risk, CL is more volatile compared to KMB. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check KMB's competition here
CL vs KVUE Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, KVUE has a market cap of 41.7B. Regarding current trading prices, CL is priced at $86.33, while KVUE trades at $21.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas KVUE's P/E ratio is 28.95. In terms of profitability, CL's ROE is +6.80%, compared to KVUE's ROE of +0.07%. Regarding short-term risk, CL is less volatile compared to KVUE. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check KVUE's competition here
CL vs EL Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, EL has a market cap of 34.3B. Regarding current trading prices, CL is priced at $86.33, while EL trades at $95.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas EL's P/E ratio is -39.36. In terms of profitability, CL's ROE is +6.80%, compared to EL's ROE of -0.18%. Regarding short-term risk, CL is less volatile compared to EL. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check EL's competition here
CL vs CHD Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, CHD has a market cap of 22.8B. Regarding current trading prices, CL is priced at $86.33, while CHD trades at $93.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas CHD's P/E ratio is 44.19. In terms of profitability, CL's ROE is +6.80%, compared to CHD's ROE of +0.16%. Regarding short-term risk, CL is less volatile compared to CHD. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check CHD's competition here
CL vs SGI Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, SGI has a market cap of 17B. Regarding current trading prices, CL is priced at $86.33, while SGI trades at $80.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas SGI's P/E ratio is 55.46. In terms of profitability, CL's ROE is +6.80%, compared to SGI's ROE of +0.16%. Regarding short-term risk, CL is less volatile compared to SGI. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check SGI's competition here
CL vs CLX Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, CLX has a market cap of 15B. Regarding current trading prices, CL is priced at $86.33, while CLX trades at $122.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas CLX's P/E ratio is 18.85. In terms of profitability, CL's ROE is +6.80%, compared to CLX's ROE of +8.83%. Regarding short-term risk, CL is more volatile compared to CLX. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check CLX's competition here
CL vs HIMS Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, HIMS has a market cap of 10.5B. Regarding current trading prices, CL is priced at $86.33, while HIMS trades at $48.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas HIMS's P/E ratio is 61.16. In terms of profitability, CL's ROE is +6.80%, compared to HIMS's ROE of +0.38%. Regarding short-term risk, CL is less volatile compared to HIMS. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check HIMS's competition here
CL vs ELF Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, ELF has a market cap of 7B. Regarding current trading prices, CL is priced at $86.33, while ELF trades at $122.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas ELF's P/E ratio is 72.72. In terms of profitability, CL's ROE is +6.80%, compared to ELF's ROE of +0.22%. Regarding short-term risk, CL is less volatile compared to ELF. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check ELF's competition here
CL vs NTCO Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, CL is priced at $86.33, while NTCO trades at $6.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas NTCO's P/E ratio is -11.37. In terms of profitability, CL's ROE is +6.80%, compared to NTCO's ROE of -0.43%. Regarding short-term risk, CL is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check NTCO's competition here
CL vs COTY Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, COTY has a market cap of 4.4B. Regarding current trading prices, CL is priced at $86.33, while COTY trades at $5.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas COTY's P/E ratio is -10.76. In terms of profitability, CL's ROE is +6.80%, compared to COTY's ROE of -0.10%. Regarding short-term risk, CL is less volatile compared to COTY. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check COTY's competition here
CL vs IPAR Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, IPAR has a market cap of 3.8B. Regarding current trading prices, CL is priced at $86.33, while IPAR trades at $118.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas IPAR's P/E ratio is 23.56. In terms of profitability, CL's ROE is +6.80%, compared to IPAR's ROE of +0.29%. Regarding short-term risk, CL is less volatile compared to IPAR. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check IPAR's competition here
CL vs NWL Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, NWL has a market cap of 2.2B. Regarding current trading prices, CL is priced at $86.33, while NWL trades at $5.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas NWL's P/E ratio is -8.76. In terms of profitability, CL's ROE is +6.80%, compared to NWL's ROE of -0.09%. Regarding short-term risk, CL is less volatile compared to NWL. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check NWL's competition here
CL vs SPB Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, SPB has a market cap of 1.4B. Regarding current trading prices, CL is priced at $86.33, while SPB trades at $59.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas SPB's P/E ratio is 26.53. In terms of profitability, CL's ROE is +6.80%, compared to SPB's ROE of +0.03%. Regarding short-term risk, CL is less volatile compared to SPB. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check SPB's competition here
CL vs EPC Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, EPC has a market cap of 1.1B. Regarding current trading prices, CL is priced at $86.33, while EPC trades at $23.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas EPC's P/E ratio is 17.44. In terms of profitability, CL's ROE is +6.80%, compared to EPC's ROE of +0.04%. Regarding short-term risk, CL is less volatile compared to EPC. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check EPC's competition here
CL vs NUS Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, NUS has a market cap of 571.7M. Regarding current trading prices, CL is priced at $86.33, while NUS trades at $11.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas NUS's P/E ratio is 5.69. In terms of profitability, CL's ROE is +6.80%, compared to NUS's ROE of +0.14%. Regarding short-term risk, CL is less volatile compared to NUS. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check NUS's competition here
CL vs HELE Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, HELE has a market cap of 553.5M. Regarding current trading prices, CL is priced at $86.33, while HELE trades at $24.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas HELE's P/E ratio is -1.66. In terms of profitability, CL's ROE is +6.80%, compared to HELE's ROE of -0.22%. Regarding short-term risk, CL is less volatile compared to HELE. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check HELE's competition here
CL vs SKIN Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, SKIN has a market cap of 301.8M. Regarding current trading prices, CL is priced at $86.33, while SKIN trades at $2.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas SKIN's P/E ratio is -13.22. In terms of profitability, CL's ROE is +6.80%, compared to SKIN's ROE of -0.33%. Regarding short-term risk, CL is less volatile compared to SKIN. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check SKIN's competition here
CL vs SLSN Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, SLSN has a market cap of 258M. Regarding current trading prices, CL is priced at $86.33, while SLSN trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas SLSN's P/E ratio is 45.75. In terms of profitability, CL's ROE is +6.80%, compared to SLSN's ROE of +0.33%. Regarding short-term risk, CL is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check SLSN's competition here
CL vs EWCZ Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, EWCZ has a market cap of 217.6M. Regarding current trading prices, CL is priced at $86.33, while EWCZ trades at $5.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas EWCZ's P/E ratio is 25.10. In terms of profitability, CL's ROE is +6.80%, compared to EWCZ's ROE of +0.13%. Regarding short-term risk, CL is less volatile compared to EWCZ. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check EWCZ's competition here
CL vs ACU Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, ACU has a market cap of 171.1M. Regarding current trading prices, CL is priced at $86.33, while ACU trades at $45.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas ACU's P/E ratio is 17.66. In terms of profitability, CL's ROE is +6.80%, compared to ACU's ROE of +0.10%. Regarding short-term risk, CL is less volatile compared to ACU. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check ACU's competition here
CL vs RAY Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, RAY has a market cap of 122.1M. Regarding current trading prices, CL is priced at $86.33, while RAY trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas RAY's P/E ratio is 46.67. In terms of profitability, CL's ROE is +6.80%, compared to RAY's ROE of +0.10%. Regarding short-term risk, CL is less volatile compared to RAY. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check RAY's competition here
CL vs DSY Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, DSY has a market cap of 64.5M. Regarding current trading prices, CL is priced at $86.33, while DSY trades at $1.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas DSY's P/E ratio is 37.66. In terms of profitability, CL's ROE is +6.80%, compared to DSY's ROE of -0.03%. Regarding short-term risk, CL is less volatile compared to DSY. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check DSY's competition here
CL vs GROV Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, GROV has a market cap of 60.7M. Regarding current trading prices, CL is priced at $86.33, while GROV trades at $1.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas GROV's P/E ratio is -2.51. In terms of profitability, CL's ROE is +6.80%, compared to GROV's ROE of -1.27%. Regarding short-term risk, CL is less volatile compared to GROV. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check GROV's competition here
CL vs UG Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, UG has a market cap of 37.5M. Regarding current trading prices, CL is priced at $86.33, while UG trades at $8.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas UG's P/E ratio is 14.59. In terms of profitability, CL's ROE is +6.80%, compared to UG's ROE of +0.22%. Regarding short-term risk, CL is more volatile compared to UG. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check UG's competition here
CL vs MTEX Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, MTEX has a market cap of 19M. Regarding current trading prices, CL is priced at $86.33, while MTEX trades at $9.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas MTEX's P/E ratio is -90.83. In terms of profitability, CL's ROE is +6.80%, compared to MTEX's ROE of -0.03%. Regarding short-term risk, CL is less volatile compared to MTEX. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check MTEX's competition here
CL vs PHH Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, PHH has a market cap of 16.2M. Regarding current trading prices, CL is priced at $86.33, while PHH trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas PHH's P/E ratio is 30.75. In terms of profitability, CL's ROE is +6.80%, compared to PHH's ROE of +0.38%. Regarding short-term risk, CL is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check PHH's competition here
CL vs BRSH Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, CL is priced at $86.33, while BRSH trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas BRSH's P/E ratio is -0.01. In terms of profitability, CL's ROE is +6.80%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, CL is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check BRSH's competition here
CL vs TANH Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, TANH has a market cap of 2.5M. Regarding current trading prices, CL is priced at $86.33, while TANH trades at $1.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas TANH's P/E ratio is -0.01. In terms of profitability, CL's ROE is +6.80%, compared to TANH's ROE of -0.03%. Regarding short-term risk, CL is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check TANH's competition here
CL vs TKLF Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, TKLF has a market cap of 1.5M. Regarding current trading prices, CL is priced at $86.33, while TKLF trades at $3.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas TKLF's P/E ratio is 2.26. In terms of profitability, CL's ROE is +6.80%, compared to TKLF's ROE of +0.00%. Regarding short-term risk, CL is less volatile compared to TKLF. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check TKLF's competition here
CL vs BRSHW Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, CL is priced at $86.33, while BRSHW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas BRSHW's P/E ratio is N/A. In terms of profitability, CL's ROE is +6.80%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, CL is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check BRSHW's competition here
CL vs SUMR Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, SUMR has a market cap of 0. Regarding current trading prices, CL is priced at $86.33, while SUMR trades at $11.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas SUMR's P/E ratio is -3.66. In terms of profitability, CL's ROE is +6.80%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, CL is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for CL.Check SUMR's competition here
CL vs REV Comparison August 2025
CL plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CL stands at 69.8B. In comparison, REV has a market cap of 0. Regarding current trading prices, CL is priced at $86.33, while REV trades at $3.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CL currently has a P/E ratio of 24.25, whereas REV's P/E ratio is -1.19. In terms of profitability, CL's ROE is +6.80%, compared to REV's ROE of +0.89%. Regarding short-term risk, CL is less volatile compared to REV. This indicates potentially lower risk in terms of short-term price fluctuations for CL.Check REV's competition here